ProShare Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.1K | Sell |
13,350
-4,347
| -25% | -$22.6K | ﹤0.01% | 1767 |
|
|
2025
Q4 | $109K | Buy |
17,697
+511
| +3% | +$3.71K | ﹤0.01% | 1857 |
|
|
2025
Q3 | $124K | Sell |
17,186
-3,155
| -16% | -$18.7K | ﹤0.01% | 1806 |
|
|
2025
Q2 | $108K | Sell |
20,341
-747
| -4% | -$4.41K | ﹤0.01% | 1868 |
|
|
2025
Q1 | $187K | Sell |
21,088
-5,894
| -22% | -$70.8K | ﹤0.01% | 1713 |
|
|
2024
Q4 | $370K | Buy |
26,982
+2,933
| +12% | +$54.1K | ﹤0.01% | 1478 |
|
|
2024
Q3 | $659K | Buy |
24,049
+4,909
| +26% | +$133K | ﹤0.01% | 979 |
|
|
2024
Q2 | $468K | Sell |
19,140
-4,853
| -20% | -$106K | ﹤0.01% | 1020 |
|
|
2024
Q1 | $512K | Buy |
23,993
+2,990
| +14% | +$64.3K | ﹤0.01% | 1070 |
|
|
2023
Q4 | $402K | Buy |
21,003
+3,334
| +19% | +$57.7K | ﹤0.01% | 1173 |
|
|
2023
Q3 | $283K | Sell |
17,669
-244
| -1% | -$4.64K | ﹤0.01% | 1241 |
|
|
2023
Q2 | $415K | Buy |
17,913
+724
| +4% | +$15.8K | ﹤0.01% | 1060 |
|
|
2023
Q1 | $399K | Sell |
17,189
-2,109
| -11% | -$42.8K | ﹤0.01% | 1021 |
|
|
2022
Q4 | $280K | Buy |
19,298
+1,554
| +9% | +$29K | ﹤0.01% | 1279 |
|
|
2022
Q3 | $338K | Buy |
17,744
+250
| +1% | +$5.74K | ﹤0.01% | 1078 |
|
|
2022
Q2 | $318K | Sell |
17,494
-8,460
| -33% | -$176K | ﹤0.01% | 1185 |
|
|
2022
Q1 | $654K | Sell |
25,954
-5,128
| -16% | -$131K | ﹤0.01% | 1120 |
|
|
2021
Q4 | $857K | Buy |
31,082
+2,455
| +9% | +$71.1K | ﹤0.01% | 1122 |
|
|
2021
Q3 | $924K | Sell |
28,627
-7,173
| -20% | -$238K | ﹤0.01% | 930 |
|
|
2021
Q2 | $1.09M | Buy |
35,800
+4,146
| +13% | +$120K | ﹤0.01% | 991 |
|
|
2021
Q1 | $964K | Buy |
31,654
+2,834
| +10% | +$80.4K | ﹤0.01% | 1007 |
|
|
2020
Q4 | $570K | Buy |
28,820
+6,704
| +30% | +$108K | ﹤0.01% | 1175 |
|
|
2020
Q3 | $288K | Sell |
22,116
-1,928
| -8% | -$24.4K | ﹤0.01% | 1202 |
|
|
2020
Q2 | $273K | Buy |
24,044
+7,079
| +42% | +$101K | ﹤0.01% | 1278 |
|
|
2020
Q1 | $243K | Sell |
16,965
-12,586
| -43% | -$266K | ﹤0.01% | 941 |
|
|
2019
Q4 | $805K | Sell |
29,551
-2,040
| -6% | -$56.1K | ﹤0.01% | 874 |
|
|
2019
Q3 | $904K | Sell |
31,591
-991
| -3% | -$28.9K | 0.01% | 777 |
|
|
2019
Q2 | $905K | Sell |
32,582
-4,841
| -13% | -$137K | 0.01% | 792 |
|
|
2019
Q1 | $1.24M | Buy |
37,423
+390
| +1% | +$11.9K | 0.01% | 705 |
|
|
2018
Q4 | $1.08M | Sell |
37,033
-4,317
| -10% | -$155K | 0.01% | 690 |
|
|
2018
Q3 | $1.9M | Sell |
41,350
-596
| -1% | -$26.5K | 0.01% | 622 |
|
|
2018
Q2 | $1.57M | Sell |
41,946
-2,654
| -6% | -$89.6K | 0.01% | 677 |
|
|
2018
Q1 | $1.32M | Sell |
44,600
-6,369
| -12% | -$215K | 0.01% | 730 |
|
|
2017
Q4 | $1.75M | Buy |
50,969
+5,041
| +11% | +$170K | 0.01% | 643 |
|
|
2017
Q3 | $1.66M | Buy |
45,928
+2,849
| +7% | +$81.3K | 0.02% | 609 |
|
|
2017
Q2 | $1.11M | Sell |
43,079
-4,068
| -9% | -$86.4K | 0.01% | 705 |
|
|
2017
Q1 | $905K | Sell |
47,147
-9,875
| -17% | -$175K | 0.01% | 783 |
|
|
2016
Q4 | $951K | Buy |
57,022
+4,852
| +9% | +$87.8K | 0.01% | 796 |
|
|
2016
Q3 | $1.07M | Sell |
52,170
-10,747
| -17% | -$273K | 0.02% | 661 |
|
|
2016
Q2 | $1.93M | Buy |
62,917
+131
| +0.2% | +$4.55K | 0.02% | 535 |
|
|
2016
Q1 | $2.35M | Sell |
62,786
-6,045
| -9% | -$228K | 0.03% | 406 |
|
|
2015
Q4 | $2.97M | Buy |
68,831
+7,340
| +12% | +$310K | 0.04% | 399 |
|
|
2015
Q3 | $2.31M | Sell |
61,491
-6,551
| -10% | -$233K | 0.03% | 442 |
|
|
2015
Q2 | $2.31M | Buy |
68,042
+7,051
| +12% | +$240K | 0.03% | 464 |
|
|
2015
Q1 | $2.16M | Buy |
60,991
+8,727
| +17% | +$312K | 0.03% | 537 |
|
|
2014
Q4 | $1.78M | Buy |
52,264
+11,966
| +30% | +$425K | 0.02% | 599 |
|
|
2014
Q3 | $1.55M | Sell |
40,298
-8,443
| -17% | -$315K | 0.02% | 863 |
|
|
2014
Q2 | $1.9M | Sell |
48,741
-10,099
| -17% | -$376K | 0.02% | 782 |
|
|
2014
Q1 | $2.01M | Buy |
58,840
+23,480
| +66% | +$727K | 0.03% | 746 |
|
|
2013
Q4 | $742K | Buy |
35,360
+4,753
| +16% | +$120K | 0.01% | 1019 |
|
|
2013
Q3 | $719K | Buy |
30,607
+13,188
| +76% | +$375K | 0.02% | 1132 |
|
|
2013
Q2 | $468K | Buy |
+17,419
| New | +$505K | 0.01% | 1382 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
ProShare Advisors's MYGN Position: Q1 2026 in Review
ProShare Advisors reduced its Myriad Genetics (MYGN) stake by 25% in Q1 2026, selling an estimated $22.6K and leaving 13,350 shares worth $60.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1767.
ProShare Advisors first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.97M in Q4 2015. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- ProShare Advisors held 13,350 shares of Myriad Genetics worth $60.1K as of Q1 2026.
- ProShare Advisors sold 4,347 Myriad Genetics shares in Q1 2026, an estimated $22.6K.
- Myriad Genetics made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1767 holding.
- ProShare Advisors first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Myriad Genetics position peaked at $2.97M in Q4 2015.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.